TOPLINE:

A meta-analysis found higher prevalence rates of autoimmune comorbidities, particularly thyroid disease, alopecia areata, rheumatoid arthritis, and type 1 diabetes in adults with vitiligo.

METHODOLOGY:

Researchers conducted a meta-analysis of eight observational studies published between 2012 and 2022 that evaluated the prevalence of autoimmune comorbidities among 10,246 adults with vitiligo in the US.

Studies compared patients with vitiligo to the general population, individuals without vitiligo, or healthy control participants.

Study outcomes included pooled prevalence rates of various autoimmune comorbidities.

TAKEAWAY:

In patients with vitiligo, thyroid disease was the most common comorbidity (pooled prevalence, 13.6%), followed by psoriasis (5.1%), rheumatoid arthritis

See Full Page